Pages
Products
Human PARP1 Knockout Cell Line-HEK293T

Human PARP1 Knockout Cell Line-HEK293T

Cat.No. :  CSC-RT1113

Host Cell:  HEK293T Target Gene:  PARP1

Size:  1x10^6 cells/vial, 1mL Validation:  Sequencing

Inquire for Price

Cell Line Information

Cell Culture Information

Safety and Packaging

Gene Informationn

Cat. No. CSC-RT1113
Description A stable cell line with a homozygous knockout of human PARP1 using CRISPR/Cas9.
Target Gene PARP1
Host Cell HEK293T
Host Cell Species Homo sapiens (Human)
Shipping 10^6 cells/tube
Storage Liquid nitrogen
Revival Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media.
Media Type Cells were cultured in DMEM supplemented with 10% fetal bovine serum.
Growth Properties Cells are cultured as a monolayer at 37°C in a humidified atmosphere with 5% CO2. Split at 80-90% confluence, approximately 1:3-1:6.
Freeze Medium Complete medium supplemented with 10% (v/v) DMSO
Gene Name
Gene ID
Mycoplasma Negative
Format One frozen vial containing millions of cells
Storage Liquid nitrogen
Safety Considerations

The following safety precautions should be observed.

1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum.

2. No eating, drinking or smoking while handling the stable line.

3. Wash hands after handling the stable line and before leaving the lab.

4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells.

5. All waste should be considered hazardous.

6. Dispose of all liquid waste after each experiment and treat with bleach.

Ship Dry ice
Quick Inquiry

Background

Case Study

Applications

Publications

Q & A

Customer Reviews

PARP1, or poly (ADP-ribose) polymerase 1, is a key enzyme in the PARP family of proteins that plays an important role in various cellular processes, especially in maintaining genomic integrity. The enzyme is best known for its involvement in the DNA repair process, especially in the case of single-strand breaks (SSBs). When DNA damage occurs, PARP1 quickly detects the DNA strand break and binds to the DNA at the site of damage. Once attached, PARP1 catalyzes the addition of ADP-ribose units from NAD+ to target proteins, including itself, in a process called poly ADP-ribosylation. This post-translational modification signals the site and recruits other DNA repair machinery, promoting efficient and rapid repair of damaged DNA. Through this mechanism, PARP1 helps maintain genomic stability and prevents mutations that can lead to diseases such as cancer. In addition to DNA repair, PARP1 is involved in a variety of other cellular mechanisms. It regulates transcription by modifying chromatin structure, which affects gene expression. It is also involved in regulating cell death pathways, inflammation, and even cellular stress responses. Inhibitors of PARP1, or PARP inhibitors (PARPi), have emerged as promising therapeutic agents, particularly for cancers with defective homologous recombination (HR) repair mechanisms, such as BRCA1 or BRCA2 mutant cancers. These tumors rely heavily on PARP-mediated DNA repair, and inhibition of PARP1 can lead to synthetic lethality, selectively killing cancer cells while sparing normal cells.

In human melanoma, PARP-1 and HIF-1α expression are tightly linked. Upon hypoxic stimulation, poly(ADP-ribose) (PAR) is synthesized and HIF-1α is post-transcriptionally modified (PTM) and stabilized by PARylation of specific K/R residues located at its C-terminus. Using an unbiased ChIP-seq approach, researchers demonstrate that PARP-1 dictates hypoxia-dependent HIF recruitment to chromatin at a range of HIF-regulated genes, while analysis of HIF-binding motifs (RCGTG) reveals that recognition of hypoxia-responsive elements is restricted in the absence of PARP-1. As a result, cells are less adaptable to hypoxia and exhibit reduced fitness during hypoxia induction. These data describe a fine-tuned regulation of HIF activation by PARP-1/PARylation and suggest that PARP inhibitors may have therapeutic potential for cancer types that exhibit HIF-1α hyperactivation.

ChIP-Seq analysis was performed on HEK 293T WT and HEK 293T PARP-1 knockout (PARP-1 KO) cells during early hypoxia (4 hours). ChIP-Seq showed that the majority of HIF-1α binding peaks detected were located within the first kilobase upstream of the translation start site: 48.16% for wild type and 43.9% for PARP-1 KO (Figure 1), which includes the 5′-UTR and promoter region of the gene. Statistical analysis was completed to eliminate non-significant peaks and compare them to input and normoxic control signals. 123 peaks were detected in hypoxic wild type cells and 68 peaks were detected in PARP-1 KO cells.

Figure 1. Chip-seq analysis of HIF-1α capacity to bind the promoters of its target genes on WT vs. PARP-1 knockout cells.Figure 1. Chip-seq analysis of HIF-1α capacity to bind the promoters of its target genes on WT vs. PARP-1 knockout cells. (Martí, Juan Manuel, et al. 2021)

PARP1 is a key enzyme involved in the DNA repair process, and knocking out this enzyme provides insights into a variety of cellular mechanisms and disease models. Here are some important applications: Cancer Research: PARP1 knockout in HEK293T cells provides an important tool for studying the role of PARP1 in cancer development and treatment, especially in understanding DNA repair mechanisms and the efficacy of PARP inhibitors in cancer treatment. Drug Screening and Development: This cell line is very useful for high-throughput screening of potential PARP inhibitors, helping to identify novel therapeutic agents and assess their effectiveness without interfering with endogenous PARP1 activity. Genomic Stability Studies: Researchers use these knockout cells to study pathways involving PARP1 in maintaining genomic integrity, studying how the loss of PARP1 affects DNA damage response and repair mechanisms. Pathway Analysis: The loss of PARP1 provides an ideal model for dissecting the cellular pathways affected by PARP1, including those involved in apoptosis, necrosis, and cell signaling, allowing for a clearer understanding of its role in various biological processes. Neurological Research: Given the role of PARP1 in neuronal cell death and neuroinflammation, this knockout cell line can be used as a model to explore neurodegenerative diseases.
Customer Q&As
What is the recommended growth medium? Does it require antibiotic selection?

A: DMEM supplemented with 10% fetal bovine serum.
It is not required to add the selection antibiotics when culturing the KO cells.

How is the knockout cell line validated?

A: The knockout cell product is validated by PCR amplification and Sanger Sequencing to confirm the mutation at the genomic level. Please find the detailed mutation info in the datasheet.

Is the product a single clonal cell or mixed cell pool?

A: Single clonal cell.

Can I confirm gene knockout by RT-qPCR?

A: No. This knockout cell product is generated using the CRISPR/Cas9 system to induce small insertions or deletions (indels) resulting in frameshift mutations. Although these frameshift mutations typically disrupt the coding gene, there is a possibility that the non-functional transcript may still be transcribed. Consequently, this could potentially yield misleading results when analyzed by RT-qPCR.

How can I store the cell product?

A: The cell line should be stored in liquid nitrogen for long-term preservation.

Is it possible to get multiple knockout clones for my GOI?

A: For most cases, we often keep at least 2 clones with different frameshift mutations. Please feel free to contact us to check if there are additional available clones.

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Invaluable tool

PARP1 knockout cells offer a model to help me understand the various mechanisms of DNA repair. I recommend Creative Biogene'cell line.

United States

11/03/2022

Helpful

We are now working on developing PARP inhibitors for use in humans. These PARP1 knockout cell lines are very helpful for our research.

United States

02/23/2023

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction

CBpromise

Our promise to you:
Guaranteed product quality, expert customer support.

24x7 CUSTOMER SERVICE
CONTACT US TO ORDER